ACESION PHARMA ApS: Financial statements 2014
CVR: 34083738
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -4,722,342 and a net result of DKK -6,455,117 compared with DKK -6,507,161 the year before. Equity in the 2014 report amounted to DKK 3,831,501. The solvency ratio was 20.3%.
- Gross Profit
- DKK -4,722,342
- Profit/Loss
- DKK -6,455,117
- Equity
- DKK 3,831,501
- Total Assets
- DKK 18,886,932
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -4.7 mio. | -6.5 mio. | 3.8 mio. | - |
| 2013 | - | -4.8 mio. | -6.5 mio. | -556 t. | - |
| 2012 | - | -1.3 mio. | -2.1 mio. | 2 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of August 1, 2014, Bobby G Soni has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Ingelise Saunders has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Carsten Schou has joined the board of directors of ACESION PHARMA ApS.
As of August 1, 2014, Frank Knudsen has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -4,833,419, and the net result was DKK -6,507,161.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The board consists of Jørgen Søberg Petersen (chair), Benjamin Bruno Thorner, Nik Economopoulos and Timothy Michael Shannon. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees (2018). In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity in the 2025 report amounted to DKK 276,067,000.